For HCPs Only
Recent Clinical Updates
Loading latest clinical updates

Clinical Intelligence & Drug Records for US-Licensed Practitioners

The integrated, institutional-grade registry trusted by US-licensed practitioners for evidence-based clinical data, drug information, and peer-reviewed drug updates.

Drug Update Briefing

Weekly drug approvals, safety updates, and specialty coverage for healthcare professionals.

Clinical Resources

Drug updates, reference data, and specialist-led coverage.

Recent Clinical Updates

Latest Drug & Specialty Updates

View All

Specialty Coverage

Therapeutic-area updates for clinical review.

All Specialties

Drug Information

FDA drug records and prescribing context.

Review drug records, NDC references, dosage tools, and interaction resources alongside clinical coverage.

Clinical Coverage

Additional Drug Updates

Gastroenterology

FDA Approves Bulevirtide for Chronic Hepatitis Delta Virus: New Treatment Algorithm Released

May 29|3 min read|By Dr. Sanjay Iyer
Neurology

FDA Approves Lecanemab for Alzheimer: First Subcutaneous Anti-Amyloid Therapy

May 29|3 min read|By Dr. Vikram Patel
Rheumatology

FDA Approves Anifrolumab for Subcutaneous Home Administration in SLE

May 29|3 min read|By Dr. Deepak Nair
Endocrinology

FDA Approves Teplizumab for Type 1 Diabetes: Expanded Indication for Ages 1 and Above

May 29|3 min read|By Dr. Amit Desai
Endocrinology

FDA Approves Afrezza for Pediatric Use: First Needle-Free Insulin for Ages 4-17

May 29|3 min read|By Dr. Amit Desai
Dermatology

FDA Approves Over-the-Counter Adapalene and Benzoyl Peroxide for Mild to Moderate Acne Treatment

May 29|3 min read|By Dr. Divya Agarwal
Rheumatology

FDA Approves First Interchangeable Biosimilars for Rheumatoid Arthritis: Cost Savings and Formulary Implications

May 29|3 min read|By Dr. Deepak Nair
Rheumatology

FDA Approves Immgolis as First Interchangeable Golimumab Biosimilar for RA and UC

May 29|3 min read|By Dr. Deepak Nair
Pulmonology

WHO Releases 2026 Smoking Cessation Guidelines: Cytisinicline vs Varenicline vs NRT vs Bupropion

May 29|3 min read|By Dr. Nikhil Chatterjee
Oncology

Zanubrutinib and Acalabrutinib: New Treatment Paradigms for Mantle Cell Lymphoma

May 29|3 min read|By Dr. Rahul Verma
Infectious Disease

COVID-19 Treatment Options: Comparing Ensitrelvir, Paxlovid, and Lagevrio

May 29|3 min read|By Dr. Simran Kohli
Pharmacology

FDA Approves Bulevirtide for Chronic Hepatitis Delta: First Treatment Available

May 29|3 min read|By Editorial Team
Rheumatology

FDA Approves Deucravacitinib for Psoriatic Arthritis: 54% Joint Swelling Reduction

May 29|3 min read|By Dr. Deepak Nair
Dermatology

FDA Approves Adapalene and Benzoyl Peroxide for OTC Acne Treatment: New Nonprescription Gel

May 29|3 min read|By Dr. Divya Agarwal
Gastroenterology

FDA Approves Bulevirtide for Chronic Hepatitis Delta Virus: First Treatment Option Available

May 29|3 min read|By Dr. Sanjay Iyer
Cardiology

Baxdrostat Reduces Resistant Hypertension: New Treatment Algorithm for 2026

May 29|3 min read|By Dr. Kavya Sharma
Gastroenterology

FDA Approves New Biologics Algorithm for Ulcerative Colitis: Golimumab, Vedolizumab, Upadacitinib, and More

May 29|3 min read|By Dr. Sanjay Iyer
Infectious Disease

CDC Updates Hepatitis B Vaccination Guidelines: Universal Vaccination for Adults 19-59 and Catch-Up for Those Over 60

May 29|3 min read|By Dr. Simran Kohli
Pulmonology

Trimbow vs Trelegy: New Guidelines for Severe Asthma Management

May 29|3 min read|By Dr. Nikhil Chatterjee
Neurology

FDA Approves Efgartigimod for All Serotypes of Generalized Myasthenia Gravis

May 26|3 min read|By Dr. Vikram Patel
Neurology

FDA Approves Lecanemab for Alzheimer: Weekly Home Administration Option

May 26|3 min read|By Dr. Aditi Kulkarni
Neurology

FDA Approves Efgartigimod for Myasthenia Gravis: New Treatment Algorithm for All Serotypes

May 26|3 min read|By Dr. Aditi Kulkarni
Infectious Disease

FDA Approves Doravirine and Islatravir for HIV-1: Once Daily Two-Drug Regimen

May 26|3 min read|By Dr. Simran Kohli